Strand Hanson Wins $7M Over Unpaid Pharma Merger Fee
A London court ruled on Tuesday that a pharmaceutical development company owes financial adviser Strand Hanson Ltd. $7 million for an unpaid fee plus damages stemming from a merger worth about...To view the full article, register now.
Already a subscriber? Click here to view full article